- AstraZeneca: UBS downgrades from buy to neutral targeting GBp 10,100.
- Burberry: Kepler Cheuvreux downgrades to hold from buy. PT up 2.9% to 1,650 pence.
- Duke Realty: Edward Jones downgrades to hold from buy.
- Envista Holdings: Baird cuts to neutral from outperform, price target to $46 from $54.
- Henry Schein: Baird downgrades to neutral from outperform. PT up 12% to $88.
- NetApp: Baird downgrades to neutral from outperform. PT up 12% to $88.
- Nike: HSBC retains his Neutral opinion on the stock. The target price has been revised downwards and is now set at USD 132 as compared to USD 140 previously.
- Omnicom: Edward Jones downgrades to hold from buy.
- Oracle: Jefferies maintained its neutral recommendation. The target price has been lifted and is now set at USD 80 compared to USD 75 before.
- PBF Energy: Wells Fargo Securities upgrades to overweight from equal-weight.
- Phillips 66: BMO Capital Markets initiated coverage with a recommendation of outperform. PT set to $132.
- ReNeuron: Liberum starts tracking as a buy, targeting GBp 80.
- Valero Energy: BMO Capital Markets initiated coverage with a recommendation of market perform. PT up 18% to $155.
- Viad Corp: Oppenheimer & Co initiated coverage with a recommendation of outperform. PT set to $42.
- Walmart: Evercore ISI adjusts price target to $130 from $135, maintains in-line rating.
- Wizz Air: HSBC moves the stock from "light" to "hold" with a target of GBp 2200. Berenberg upgrades from hold to buy targeting GBp 3300.
- YouGov: Liberum starts tracking at buy, targeting GBp 1500.